JAK1 and vitiligo: JAK1 and particularly JAK3 showed overexpression in the skin of vitiligo patients compared with the controls, with a gradual shift from nonlesional to perilesional and lesional sections, with no correlation between the expression levels of JAK1 and JAK3 and disease activity or severity.